Omega Healthcare Investors Inc (NYSE:OHI) insider Michael Ritz sold 6,000 shares of the stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $34.75, for a total transaction of $208,500.00. Following the completion of the sale, the insider now directly owns 10,076 shares in the company, valued at approximately $350,141. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Shares of OHI traded down $0.09 during mid-day trading on Monday, hitting $35.20. The company’s stock had a trading volume of 86,672 shares, compared to its average volume of 2,400,132. The stock has a market capitalization of $7.08 billion, a P/E ratio of 10.67, a P/E/G ratio of 5.95 and a beta of 0.13. The company has a debt-to-equity ratio of 1.21, a current ratio of 4.17 and a quick ratio of 4.17. Omega Healthcare Investors Inc has a fifty-two week low of $24.90 and a fifty-two week high of $35.61.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Monday, November 5th. The real estate investment trust reported $0.28 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.74 by ($0.46). The business had revenue of $192.30 million during the quarter, compared to analyst estimates of $194.40 million. Omega Healthcare Investors had a return on equity of 7.32% and a net margin of 31.91%. The business’s revenue for the quarter was down .9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.79 EPS. As a group, equities research analysts forecast that Omega Healthcare Investors Inc will post 2.97 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 15th. Stockholders of record on Wednesday, October 31st were paid a $0.66 dividend. The ex-dividend date was Tuesday, October 30th. This represents a $2.64 annualized dividend and a dividend yield of 7.50%. Omega Healthcare Investors’s dividend payout ratio is currently 80.00%.

Several institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. boosted its holdings in shares of Omega Healthcare Investors by 2.7% in the third quarter. BlackRock Inc. now owns 22,472,026 shares of the real estate investment trust’s stock worth $736,410,000 after buying an additional 600,867 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Omega Healthcare Investors by 14.9% in the second quarter. Bank of New York Mellon Corp now owns 5,689,457 shares of the real estate investment trust’s stock worth $176,373,000 after buying an additional 736,393 shares during the period. Daiwa Securities Group Inc. boosted its holdings in shares of Omega Healthcare Investors by 43.9% in the second quarter. Daiwa Securities Group Inc. now owns 5,032,761 shares of the real estate investment trust’s stock worth $156,015,000 after buying an additional 1,536,523 shares during the period. LSV Asset Management boosted its holdings in shares of Omega Healthcare Investors by 0.7% in the second quarter. LSV Asset Management now owns 4,899,233 shares of the real estate investment trust’s stock worth $151,876,000 after buying an additional 32,500 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Omega Healthcare Investors by 0.4% in the third quarter. Dimensional Fund Advisors LP now owns 3,115,660 shares of the real estate investment trust’s stock worth $102,097,000 after buying an additional 11,565 shares during the period. 73.10% of the stock is currently owned by institutional investors.

Several equities analysts have commented on the stock. Zacks Investment Research raised shares of Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Wednesday, October 31st. TheStreet raised shares of Omega Healthcare Investors from a “c” rating to a “b-” rating in a research note on Thursday, November 8th. MED raised their target price on shares of Omega Healthcare Investors to $34.00 and gave the company a “neutral” rating in a research note on Monday, November 5th. Stifel Nicolaus set a $34.00 target price on shares of Omega Healthcare Investors and gave the company a “hold” rating in a research note on Monday, November 5th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $34.00 target price on shares of Omega Healthcare Investors in a research note on Monday, August 6th. Nine investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Omega Healthcare Investors currently has an average rating of “Hold” and an average price target of $32.50.

COPYRIGHT VIOLATION NOTICE: This report was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2018/11/19/omega-healthcare-investors-inc-ohi-insider-sells-208500-00-in-stock.html.

About Omega Healthcare Investors

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Featured Article: Trading Penny Stocks

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.